Drug Trial Radar · NCT06014424
Cannabidiol Medication Intervention Trial
Last checked: Nov 20, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
40
Planned (sponsor's estimate)
Start
Sep 27, 2023
Primary completion
Dec 2027
Study completion Dec 2027
Sponsor
- Lead sponsor
- Sunnybrook Health Sciences CentreAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Weston Brain Institute
- First posted
- Aug 28, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 55 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
CALM-IT is a Randomized, double-blind, placebo-controlled cross-over clinical trial. Safety and efficacy of cannabidiol (CBD) capsules assessed for managing agitation in patients with AD and to identify novel biomarkers of agitation severity and treatment response.
Conditions
- Alzheimer Disease
Interventions
CBDDrug
Cannabidiol will be titrated to a maximum dose of 800mg per day.
PlaceboDrug
Placebo capsules will be increased to match the CBD titration schedule.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Agitation as measured by the Cohen-Mansfield Agitation Inventory (CMAI)Time frame: Up to 21 weeks
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
University of Calgary
Calgary, Alberta, Canada · Recruiting
London Health Sciences Centre
London, Ontario, Canada · Recruiting
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada · Recruiting
Centre for Addiction and Mental Health
Toronto, Ontario, Canada · Recruiting
Ontario Shores Centre for Mental Health Sciences
Whitby, Ontario, Canada · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.